Allergan plc reported second quarter 2016 results, including total net revenues of $3.7% billion, a 2% increase compared with the prior year quarter, according to a press release.The revenues were impacted by the loss of exclusivity on Nameda IR, but offset by key brands’ strong performances, according to the release.
Author: Healio ophthalmology
Aerie Pharmaceuticals reports net loss of $23.2 million in second quarter
Aerie Pharmaceuticals reported a net loss attributable to common stockholders of $23.2 million, or $0.87 per share, in the second quarter compared with a net loss of $18.8 million, or $0.73 per share, in the same period last year, according to a press release.The net loss was attributed to $13.3 million in research and development expenses and $9.4 million in general and administrative expenses. Higher operating expenses compared with last year included expansion of the company’s employee base to support growth of operations.
COVER STORY: Retina specialists explore anti-VEGF treatments for diabetic eye disease
As the rising prevalence of diabetes drives demand for care across medical specialties, ophthalmologists are increasingly focused on the causes, prevention and treatment of diabetic eye disease.Overall, 4.2 million adults have diabetic retinopathy and …
VIDEO: Speaker gives pearls for challenging cases of MIGS
At Kiawah Eye, Savak “Sev” Teymoorian, MD, MBA, gives pearls on challenging cases of minimally invasive glaucoma surgery.
Valeant announces leadership changes
Valeant Pharmaceuticals International has announced leadership and organizational changes.Christina Ackermann has been named executive vice president and general counsel, according to a press release. She succeeds Robert Chai-Onn, who will leave Valean…
Ophthotech reports $29.9 million net loss in second quarter
Ophthotech reported a net loss of $29.9 million in the second quarter, or $0.85 per diluted share, compared with a net loss of $37.1 million, or $1.08 per diluted share, in the second quarter of 2015, according to a press release.Quarterly collaboratio…
Physicians with in-office clinical laboratories should prepare for new mandates
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.Performing laboratory tests in your office and billing Medicare? If so, you could be required to comply with a new federal mandate to report information on your revenue from laboratory testing.
Ocular Therapeutix addresses most FDA concerns about Dextenza NDA
Ocular Therapeutix provided an update on its new drug application for Dextenza, according to a press release.In July, the FDA raised concerns in a complete response letter regarding deficiencies in the manufacturing process and controls that were identified during a pre-NDA approval inspection of the company’s manufacturing facility.
Precizon toric IOL improves vision, provides rotational stability
Implantation of a transitional toric monofocal IOL improved vision and offered rotational stability in eyes with cataract and corneal astigmatism, a study performed in Portugal found.The prospective case series included 51 eyes of 39 patients with 1 D …
VIDEO: Speaker gives update on Kamra inlay
At Kiawah Eye, Kerry D. Solomon, MD, discusses AcuFocus’ Kamra inlay as an effective solution for the treatment of presbyopia.
VIDEO: Ocular surface optimization prior to refractive cataract surgery
At Kiawah Eye, Neel R. Desai, MD, shares reasons why he believes surgeons should use ocular surface optimization on refractive patients prior to surgery.
Speaker: Nursing research starts with questions, passion and open mind
CLEVELAND —Rheumatology nurses need to approach the idea of doing nursing research with an open mind and use their passion to answer questions for the benefits of their patients and the improvement of patient care, said a presenter at the Rheumatology Nurses Society Annual Conference.“Research can be a beautiful process. I want you to know that it is a process and it [is] going to take some time — but you want to go ahead and get to the fun stuff — that is your research project and see what (Read more...)
VIDEO: Treatment, management options for patients with intermediate uveitis
At Hawaiian Eye, Nisha Acharya, MD, MS, discusses treatment and management options for patients with intermediate uveitis.
National survey shows citizens concerned with vision health but unaware of important eye diseases
A national survey of U.S. residents across all ethnic and racial groups showed good vision health was a priority, with respondents also showing high support for ongoing research for vision and eye health. The online nationwide poll included 2,044 U.S. adults. Poll questions measured respondents’ attitudes on the importance of eye health, concerns about vision loss, support for eye health research, and awareness of eye diseases and risk factors, according to the results published in JAMA Ophthalmology.
Study: Former contact lens wearers report high satisfaction with LASIK
Contact lens wearers who chose to have LASIK are more satisfied with their vision a year postoperatively and most satisfied after 2 to 3 years, according to a recent study in Ophthalmology.After LASIK, former contact lens wearers reported higher satisf…
Regeneron reports 21% rise in total revenues for second quarter
Total revenues for Regeneron increased by 21% to $1.213 billion in the second quarter, up from $999 million in the second quarter of 2015, according to a press release.U.S. net sales of Eylea (aflibercept) increased 27% to $831 million, up from $655 mi…
Duke researchers develop hand-held device to take high-resolution images of children’s retinas
A new hand-held device capable of taking images of a child’s retina with cellular resolution has been developed by engineers and physicians at Duke University, according to a university press release.The ultra-compact hand-held device, which is based on OCT and other technologies, allows researchers to gather structural information about the eyes of infants and toddlers for the first time.
VIDEO: Speaker talks about type 1 vs type 3 neovascularization in patients with AMD
At Retina 2016, David Sarraf, MD, compares type 1 and type 3 neovascularization visualized by OCT angiography in patients with age-related macular degeneration.
Study: Color discernment may improve after DMEK in patients with Fuchs’ endothelial corneal dystrophy
The majority of patients with Fuchs’ endothelial corneal dystrophy who underwent Descemet’s membrane endothelial keratoplasty showed an improvement in color discernment scores after surgery, according to a study. The prospective, single-center study included 26 eyes of 26 patients with Fuchs’ endothelial corneal dystrophy who underwent DMEK; 24 eyes were pseudophakic and two eyes were phakic.
Jim Mazzo talks with OSN about his new role as global president of Ophthalmology for Zeiss
James V. Mazzo has taken the reins of the ophthalmology and optometry business worldwide for Carl Zeiss Meditec. Having worked for more than three decades in the ophthalmic and medical device industries, Mazzo left AcuFocus, where he was chairman and CEO, and without skipping a beat, began acting in his new role as global president of Zeiss’ new consolidated strategic business unit Ophthalmology on Aug. 1. Ocular Surgery News talked with him about his plans.